Skip to main content
. 2024 Apr 20;25(5):e14361. doi: 10.1002/acm2.14361

TABLE 3.

Median values and interquartile ranges of dosimetric parameters for our cohort of 200 left‐sided patients.

  Dose constraints
PTV Heart Ipsilateral lung Contralateral breast
Strategy V95 (%) V90 (%) D max(%) D5% (cGy) V8Gy (%) D med (cGy) V16Gy (%) V8Gy (%) V4Gy (%) D max (cGy)
G1OpS1 Median (IQR) 92.75 (6.55) 95.50 (4.06) 106.20 (1.20) 823.37 (825.47) 5.09 (4.08) 294.19 (82.81) 11.60 (5.16) 16.18 (5.80) 27.06 (8.61) 1249.16 (3320.23)
G1OpS2 Median (IQR) 92.58 (7.11) 95.52 (3.97) 106.34 (1.18) 666.79 (572.19) 4.49 (2.63) 282.98 (59.66) 11.14 (4.97) 15.55 (5.36) 26.64 (8.01) 757.54 (2224.52)
G1OpS3 Median (IQR) 92.96 (6.68) 95.61 (3.88) 106.52 (1.19) 704.53 (707.63) 4.66 (3.24) 288.12 (71.86) 11.34 (5.13) 15.72 (5.60) 26.84 (7.99) 792.64 (2381.97)
G2OpS1 Median (IQR) 96.19 (4.31) 99.04 (1.62) 106.08 (1.12) 1062.39 (487.95) 6.83 (4.08) 294.71 (65.09) 12.12 (4.35) 18.75 (5.02) 31.58 (7.95) 667.25 (2697.09)
G2OpS2 Median (IQR) 95.74 (4.86) 98.87 (1.74) 106.26 (1.27) 782.89 (328.15) 4.90 (1.80) 270.98 (31.62) 11.83 (3.80) 17.89 (4.56) 30.18 (7.49) 510.97 (1538.56)
G2OpS3 Median (IQR) 96.08 (4.70) 98.90 (1.85) 106.39 (1.39) 826.15 (396.18) 5.12 (2.00) 276.21 (41.65) 11.96 (4.15) 18.28 (4.99) 30.31 (7.63) 521.63 (1707.61)
G3OpS1 Median (IQR) 96.21 (4.06) 98.97 (1.62) 106.28 (1.34) 1042.49 (314.79) 7.68 (4.50) 309.84 (57.53) 12.31 (3.77) 19.60 (5.63) 39.12 (11.92) 536.94 (2425.78)
G3OpS2 Median (IQR) 95.64 (4.49) 98.74 (1.81) 106.44 (1.55) 768.04 (242.66) 4.81 (1.51) 267.67 (24.64) 12.02 (3.35) 18.89 (4.90) 35.65 (11.93) 451.83 (1361.69)
G3OpS3 Median (IQR) 95.98 (4.23) 98.81 (1.91) 106.64 (1.58) 799.64 (300.20) 5.00 (1.69) 271.88 (32.35) 12.13 (3.62) 18.71 (4.86) 35.22 (11.75) 481.29 (1599.15)